O Keefe Stevens Advisory Inc. increased its holdings in Perrigo Company plc (NYSE:PRGO - Free Report) by 8.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 198,129 shares of the company's stock after buying an additional 15,613 shares during the period. Perrigo comprises approximately 1.6% of O Keefe Stevens Advisory Inc.'s holdings, making the stock its 20th biggest position. O Keefe Stevens Advisory Inc. owned 0.15% of Perrigo worth $5,094,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. Wellington Management Group LLP boosted its stake in Perrigo by 229.2% in the third quarter. Wellington Management Group LLP now owns 2,697,698 shares of the company's stock valued at $70,761,000 after acquiring an additional 1,878,145 shares during the period. FMR LLC lifted its holdings in shares of Perrigo by 66,795.3% in the 3rd quarter. FMR LLC now owns 1,840,289 shares of the company's stock worth $48,271,000 after purchasing an additional 1,837,538 shares during the last quarter. AQR Capital Management LLC boosted its position in Perrigo by 675.5% during the 2nd quarter. AQR Capital Management LLC now owns 970,637 shares of the company's stock valued at $24,926,000 after purchasing an additional 845,470 shares during the period. Copeland Capital Management LLC grew its stake in Perrigo by 23.1% during the 3rd quarter. Copeland Capital Management LLC now owns 2,482,544 shares of the company's stock worth $65,117,000 after buying an additional 465,161 shares during the last quarter. Finally, Deprince Race & Zollo Inc. increased its position in Perrigo by 11.2% in the second quarter. Deprince Race & Zollo Inc. now owns 3,882,438 shares of the company's stock worth $99,701,000 after buying an additional 391,646 shares during the period. Institutional investors own 95.91% of the company's stock.

Shares of Perrigo stock opened at $23.86 on Friday. Perrigo Company plc has a 52 week low of $23.14 and a 52 week high of $33.96. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. The company's 50-day moving average price is $26.49 and its two-hundred day moving average price is $26.73.

Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, hitting analysts' consensus estimates of $0.81. The business had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.12 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business's revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.64 EPS. Equities research analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th were given a dividend of $0.276 per share. This represents a $1.10 dividend on an annualized basis and a dividend yield of 4.63%. The ex-dividend date was Friday, November 29th. Perrigo's dividend payout ratio (DPR) is presently -94.02%.

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the business's stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the sale, the director now directly owns 5,409 shares of the company's stock, valued at $152,912.43. The trade was a 76.49 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.40% of the stock is currently owned by company insiders.

Several research firms have recently commented on PRGO. Argus lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Tuesday. Piper Sandler downgraded Perrigo from an "overweight" rating to a "neutral" rating and reduced their price objective for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. Jefferies Financial Group restated a "hold" rating and set a $30.00 price objective (down from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. Canaccord Genuity Group reiterated a "buy" rating and issued a $42.00 target price on shares of Perrigo in a research report on Monday, September 30th. Finally, StockNews.com lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Saturday, January 11th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Perrigo currently has a consensus rating of "Hold" and an average target price of $35.00.

View Our Latest Research Report on Perrigo

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here